Cancer Therapies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
126
NCT05597917
tTF-NGR Randomized Study - STS
Phase: Phase 3
Role: Collaborator
Start: Oct 26, 2021
Completion: Dec 31, 2026
Loading map...